Biogen (NASDAQ: BIIB) shares are moving modestly lower in pre-market Tuesday after the biotech giant reported its first-quarter results.Biogen posted ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE